Thyroid Nodule Size and Prediction of Cancer
View/ Open
Gawande_Thyroid Nodule Size vor.pdf (245.5Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Kamran, Sophia C.
Marqusee, Ellen
Kim, Mathew I.
Frates, Mary C.
Ritner, Julie
Peters, Hope
Benson, Carol B.
Doubilet, Peter M.
Cibas, Edmund S.
Barletta, Justine
Cho, Nancy
Ruan, Daniel
Moore, Francis D.
Pou, Karla
Larsen, P. Reed
Alexander, Erik K.
Published Version
https://doi.org/10.1210/jc.2012-2968Metadata
Show full item recordCitation
Kamran, Sophia C., Ellen Marqusee, Mathew I. Kim, Mary C. Frates, Julie Ritner, Hope Peters, Carol B. Benson, et al. 2013. “Thyroid Nodule Size and Prediction of Cancer.” The Journal of Clinical Endocrinology & Metabolism 98 (2): 564–70. https://doi.org/10.1210/jc.2012-2968.Abstract
Context: Thyroid nodule size is routinely measured, although its impact on thyroid cancer risk is unclear.Objective: Our objective was to evaluate the association of nodule size upon cancer risk.Design, Setting, and Patients: We conducted a retrospective cohort analysis at an academic hospital with 4955 consecutive patients evaluated between 1995 and 2009.Intervention: Ultrasound and ultrasound-guided fine-needle aspiration of nodules >1 cm was done. Indeterminate and malignant nodules were referred for surgery, and histopathology was reviewed.Main Outcome Measure: The presence and histological subtype of cancer was evaluated.Results: Of 7348 evaluated nodules, 927 (13%) were cancerous. Of those 1.0 to 1.9 cm in diameter, 10.5% were cancerous. In contrast, of those >2.0 cm, 15% were cancerous (P < .01). However, nodules 2.0 to 2.9, 3.0 to 3.9, and >4 cm were cancerous in 14%, 16%, and 15% of cases (P = .14), respectively, demonstrating no graded increase in risk beyond the 2-cm threshold. When malignant, the proportion of papillary carcinoma decreased (nodules 1.0-1.9 cm, 92% of cases; 2.0-2.9 cm, 88%; 3.0-3.9 cm, 83%; >4 cm, 74% [P < .01]), while follicular carcinoma increased (1.0-1.9 cm, 6%; 2.0-2.9 cm, 7%; 3.0-3.9 cm, 12%; >4 cm, 16% [P < .01]) as nodules enlarged. Nodules size did not influence cytology distribution or risk of false-negative aspirates.Conclusions: Increasing thyroid nodule size impacts cancer risk in a nonlinear fashion. A threshold is detected at 2.0 cm, beyond which cancer risk is unchanged. However, the risk of follicular carcinomas and other rare thyroid malignancies increases as nodules enlarge. (J Clin Endocrinol Metab 98: 564-570, 2013)Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:38846199
Collections
- HMS Scholarly Articles [17921]
Contact administrator regarding this item (to report mistakes or request changes)